$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
The zebrafish (Danio rerio) is a well-known animal model that has been widely used in research over the last 3 decades. It is a small freshwater fish that is easy to rear and breed under laboratory conditions. The zebrafish has been extensively used for various developmental and toxicological studies1,2,3,4,5,6,7,8. The zebrafish has high fecundity and short embryonic generation; the embryos are suitable for tracking different developmental stages, are visually transparent, and are amenable to varieties of genetic manipulation and high-throughput screening platforms9,10,11,12,13,14. Besides, the zebrafish provides in toto and live imaging for which its developmental process and different deformities in the presence of various toxic substances or factors can be easily studied using stereo or fluorescent microscopy7,15,16.
Radiotherapy is one of the major therapeutic modes used in treating cancer17,18,19,20,21,22,23,24. However, cancer radiotherapy demands potential radioprotectors to protect normal healthy cells from dying while killing malignant cells or safeguard human health during therapy involving high energy radiations25,26,27,28,29. Conversely, potent radiosensitizers are also being investigated to increase the efficiency of radiation to kill malignant cells, especially in targeted and precision therapies30,31,32,33. Therefore, to validate potent radioprotectors and sensitizers, a model suitable for semi-high-throughput drug screening and measurably exhibiting radiation effects is highly solicited. Several available models are used in radiation studies and involved in drug screening experiments. However, higher vertebrates and even the most commonly used in vivo model, mice, are unsuitable for large-scale drug screening because it is time-consuming, costly, and challenging to design such screening experiments with these models. Similarly, cell culture models are ideal for varieties of high-throughput drug screening experiments34,35. However, experiments involving cell culture are not always pragmatic, highly reproducible, or reliable as cells in culture may markedly change their behavior according to the growth conditions and kinetics. Also, varieties of cell types show differential radiation sensitization. Notably, 2D and 3D cell culture systems do not represent the whole organism scenario, and, thus, the results obtained may not recapitulate the actual level of radiotoxicity36,37. In this regard, the zebrafish provides several advantages in screening for novel radiosensitizers and radioprotectors. The ease of handling, large clutch size, short life span, rapid embryonic development, embryo transparency, and small body size make the zebrafish a suitable model for large-scale drug screening. Due to the above advantages, experiments can be readily repeated in a short time, and the effect can be observed easily under a dissecting microscope in multi-well plates. Hence, the zebrafish is gaining popularity in drug screening research involving radiation studies38,39.
The potential of zebrafish as a bonafide model to screen radiation modifiers has been demonstrated in various studies40,41,42,43,44,45. The radioprotective effect of potential radio modifiers, such as nanoparticle DF1, amifostine (WR-2721), DNA repair proteins KU80 and ATM, and transplanted hematopoietic stem cells, and the effects of radiosensitizers, such as flavopiridol and AG1478, in the zebrafish model have been reported19,41,42,43,44,45,46. Using the same system, the radioprotective effect of DF-1 (fullerene nanoparticle) was assessed both at systemic and organ-specific levels, and also the use of zebrafish embryos for radioprotector screening was further explored47. Recently, the Kelulut honey was reported as a radioprotector in zebrafish embryos and was found to increase embryo survival and prevent organ-specific damage, cellular DNA damage, and apoptosis48.
Similarly, the radioprotective effects of polymers generated via Hantzsch's reaction were checked on zebrafish embryos in a high-throughput screening, and the protection was mainly conferred by protecting cells from DNA damage49. In one of the previous studies, the lipophilic statin fluvastatin was found as a potential radiosensitizer using the zebrafish model with this approach50. Similarly, gold nanoparticles are considered to be an ideal radiosensitizer and have been used in many studies51,52.
The embryonic development in zebrafish involves cleavage in the initial 3 h in which a single-celled zygote divides to form 2 cells, 4 cells, 8 cells, 16 cells, 32 cells, and 64 cells that are easily identified with a stereomicroscope. Then, it attains the blastula stage with 128 cells (2.25 h post-fertilization, hpf), where the cells double every 15 min and proceed through these following stages: 256 cells (2.5 hpf), 512 cells (2.75 hpf), and reaching 1,000+ cells in just 3 h (Figure 1). At 4 h, the egg attains the sphere stage, followed by the formation of a dome shape in the embryonic mass7,53,54. The gastrulation in zebrafish starts from 5.25 hpf54, where it reaches the shield stage. The shield clearly indicates the rapid convergence movement of the cells to one side of the germ ring (Figure 1) and is a prominent and distinct phase of gastrulating embryos that can be easily identified53,54. Although radiation exposure to embryos could be done at any stage of their development, radiation exposure during gastrulation might have more distinct morphological changes facilitating better readouts of radiation-induced toxicities55; similarly, administration of drugs to embryos can be started as early as 2 hpf54.